These submissions will also disseminate advances and new approaches for personalized medicine and original, high-quality submissions reflecting new models of care. Submission should be ≤3,000 words (text from the introduction to the conclusion, including references and figure legends); please refrain ...
and practice management. These submissions will also disseminate advances and new approaches for personalized medicine and original, high-quality submissions reflecting new models of care. Submission should be ≤3,000 words (text from the introduction to the conclusion, including references and figure le...
The FDA encourages submission of PPI and provides guidance on the conduct of PPI studies. PPI is most relevant in decisions that are “preference sensitive” as in the case of AS. Preference sensitive decisions are when: 1) there is more than 1 valid treatment option; 2) data supporting ...